Huarong Bio-(02396) appoints Zhang Liting as Joint Company Secretary.
Huaren Life Sciences-B (02396) announced that Mr. He Hongtian has resigned as the joint company secretary, CFO, board secretary, and vice president due to personal affairs. Ms. Li Ting has been appointed as the joint company secretary, and Ms. Qiu Haiyan has been appointed as the CFO, board secretary, and vice president, effective as of January 30, 2026.
Huarong Biology-B (02396) announced that Mr. He Hongtian has resigned as Co-Secretary of the Company, Chief Financial Officer, Company Secretary and Vice President due to personal reasons. Ms. Zhang Liting has been appointed as Co-Secretary, and Ms. Qiu Haiyan has been appointed as Chief Financial Officer, Company Secretary and Vice President, both effective from January 30, 2026.
Related Articles
CITY COOLXUAN(08050): Deng Yongling is appointed as an independent non-executive director.
GD-HKGBA HLDGS(01396) subsidiary Hongce Data introduced Futian Capital's strategic investment and subscribed for 40% equity, injecting strong momentum into high-quality development of AI business.
QYUNS-B (02509) spent approximately HK$1.9573 million to repurchase 91,200 shares on January 30th.
CITY COOLXUAN(08050): Deng Yongling is appointed as an independent non-executive director.
GD-HKGBA HLDGS(01396) subsidiary Hongce Data introduced Futian Capital's strategic investment and subscribed for 40% equity, injecting strong momentum into high-quality development of AI business.
QYUNS-B (02509) spent approximately HK$1.9573 million to repurchase 91,200 shares on January 30th.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
